Royal Bank of Canada’s Neurotrope, Inc. Common NTRP Stock Holding History

Royal Bank of Canada’s Portfolio NTRP Stock Details NTRP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-473	Closed	-$1K	–	7490
2020 Q3	$1K	Hold	473	–	–	﹤0.01%	6551
2020 Q2	$1K	Buy	473 +115	+32%	+$144	﹤0.01%	6558
2020 Q1	$0	Buy	+358	New	+$390	﹤0.01%	7230
2019 Q4	–	Sell	-346	Closed	–	–	7296
2019 Q3	$0	Buy	+346	New	+$1.59K	﹤0.01%	7365
2018 Q4	–	Sell	-15	Closed	–	–	7363
2018 Q3	$0	Buy	+15	New	+$144	﹤0.01%	7110
2018 Q1	–	Sell	-1	Closed	–	–	7021
2017 Q4	$0	Hold	1	–	–	﹤0.01%	7093
2017 Q3	$0	Buy	+1	New	+$5	﹤0.01%	7127

Other funds holding NTRP

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Royal Bank of Canada's NTRP Position: Q4 2020 in Review

Royal Bank of Canada sold out of Neurotrope, Inc. Common (NTRP) in Q4 2020, closing a stake of 473 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in NTRP in Q3 2017 and held it in 7 quarters. The position peaked at $1K in Q3 2020. 1 fund tracked by Wall St. Rank holds NTRP as of Q4 2020.

Royal Bank of Canada reported no remaining Neurotrope, Inc. Common position as of Q4 2020 after selling out during the quarter.
Royal Bank of Canada sold 473 Neurotrope, Inc. Common shares in Q4 2020, an estimated $1K.
Royal Bank of Canada first reported a position in Neurotrope, Inc. Common in Q3 2017 and held it in 7 quarters.
Royal Bank of Canada's Neurotrope, Inc. Common position peaked at $1K in Q3 2020.
1 fund tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q4 2020.

Based on Royal Bank of Canada's 13F filing for Q4 2020, filed 16 Feb 2021.